In the journey of US IVF, the PGT (Preimplantation Genetic Testing) report is the definitive roadmap to a healthy pregnancy. As a professional medical writer and fertility consultant, I have seen how these reports can transform a family's future. PGT technology, particularly in the United States, has reached unprecedented levels of accuracy, allowing us to look deep into the genetic blueprint of an embryo before it is even transferred. This guide is designed to demystify the complex terminology—from "Euploid" and "Aneuploid" to "Mosaicism" and "Segmental Deletions"—providing you with the knowledge to discuss your results confidently with your medical team. At RSMC, we believe that an informed patient is an empowered patient, and understanding your PGT report is the first step toward a successful, healthy pregnancy.
Dr. Olivia Bennett
Fertility SpecialistMedical writer and fertility consultant focused on surrogacy, egg freezing, IVF, and family-building education. Dr. Bennett specializes in translating complex laboratory data into actionable insights for prospective parents.
What Is US PGT Report Interpretation?
US PGT report interpretation is the systematic analysis of genetic data obtained from an embryo biopsy. In a US-based laboratory, such as RSMC’s CAP/CLIA-certified facility, cells are carefully removed from the trophectoderm (the part that becomes the placenta) and analyzed for chromosomal abnormalities or specific genetic mutations.
The resulting report provides a "traffic light" system for embryo selection: identifying which embryos have the correct number of chromosomes (Euploid), which do not (Aneuploid), and which fall into the complex middle ground (Mosaic). This process is essential for reducing the risk of miscarriage, avoiding chromosomal syndromes like Down syndrome, and ensuring the highest possible live birth rate per transfer.
The Three Pillars of PGT Technology
1. PGT-A (Aneuploidy Screening)
Formerly known as PGS, this screens all 23 pairs of chromosomes. It identifies embryos with the correct count (46), which is the single most important factor in improving IVF success rates and preventing early pregnancy loss.
2. PGT-M (Monogenic/Single Gene)
Formerly PGD, this targets specific inherited disorders like Cystic Fibrosis, Thalassemia, or Huntington's Disease. Understanding the differences between PGT-A and PGT-M is vital for families with known genetic risks.
3. PGT-SR (Structural Rearrangements)
Designed for parents with balanced translocations or inversions. This specialized screening ensures the embryo has a "balanced" genetic makeup, which is critical for solving recurrent miscarriage issues.
4. Comprehensive Gender & Health
US PGT reports clearly identify sex chromosomes (XX/XY), allowing for family balancing. Combined with advanced disease screening, it provides the most complete picture of embryo health.
Decoding the Genetic Status
Euploid (Normal)
A euploid embryo contains the correct number of chromosomes (46). These embryos have the highest potential for implantation and the lowest risk of miscarriage. In a typical US PGT report, these are marked as "Normal" or "Euploid."
Aneuploid (Abnormal)
An aneuploid embryo has an incorrect number of chromosomes. This could be a "Trisomy" (an extra chromosome, like Trisomy 21/Down Syndrome) or a "Monosomy" (a missing chromosome). These embryos are generally not recommended for transfer as they often fail to implant or lead to miscarriage.
Mosaic (Mixed)
Mosaicism occurs when an embryo has two or more populations of cells with different genetic makeups (some normal, some abnormal). US labs often categorize these as "Low-Level Mosaic" (less than 40-50% abnormal cells) or "High-Level Mosaic." Recent studies show that low-level mosaic embryos can still result in healthy live births.
The Gardner Grading Scale: Beyond Genetics
While PGT tells us about the "software" (genetics), morphological grading tells us about the "hardware" (physical structure). A typical grade looks like 4AA:
4 (Expansion)
The degree of blastocyst expansion, ranging from 1 to 6. A '4' is an expanded blastocyst.
A (ICM)
The Inner Cell Mass quality (becomes the fetus). 'A' is many cells, tightly packed.
A (Trophectoderm)
The outer layer quality (becomes the placenta). 'A' is many cells forming a cohesive layer.
Troubleshooting Your PGT Report
| Common Issue | Scientific Explanation | Recommended Action |
|---|---|---|
| "No Result" / "Inconclusive" | Often due to low DNA quality or insufficient cell biopsy. | Discuss re-biopsy options with RSMC's senior embryologists. |
| High Aneuploidy Rate | Commonly linked to maternal age or sperm DNA fragmentation. | Consider protocol adjustments or our in-house egg bank for better outcomes. |
| Segmental Abnormalities | Only a piece of a chromosome is missing or extra. | Requires expert genetic counseling to assess the specific risk level. |
Get Expert Interpretation
Scan QR Code to Start Chat
Your privacy is our priority. All consultations are strictly confidential.
Frequently Asked Questions
Q: How long does it take to get PGT results?
Typically, results are available within 7 to 14 days after the embryo biopsy. At RSMC, we expedite this process to help you plan your transfer cycle as quickly as possible.
Q: Can PGT-A guarantee a 100% healthy baby?
While PGT-A is 98-99% accurate for chromosomal counts, it does not screen for every possible health condition. We always recommend standard prenatal care and NIPT testing during pregnancy.
Q: Is the biopsy safe for the embryo?
In the hands of RSMC’s expert embryologists, the risk to the embryo is less than 1%. We only biopsy blastocysts that have reached the appropriate stage of development (Day 5 or 6).
Your PGT report is the roadmap to your future child's health. Don't navigate it alone. Let RSMC's experts provide the clarity and confidence you need to take the next step in your fertility journey.